Advanced search
Publication Cover
Leukemia & Lymphoma Volume 56, 2015 - Issue 2
Submit an article Journal homepage
970
Views
6
CrossRef citations to date
0
Altmetric
Commentaries on selected articles in this issue

Ruxolitinib and DNA methyltransferase-inhibitors: a foray into combination regimens in myelofibrosis

Naval DaverDepartment of Leukemia, M. D. Anderson Cancer Center, Houston, TX, USACorrespondence[email protected]
&
Srdan VerstovsekDepartment of Leukemia, M. D. Anderson Cancer Center, Houston, TX, USA
Pages 279-280 | Published online: 15 Jul 2014

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Anna Orlova, Bettina Wingelhofer, Heidi A. Neubauer, Barbara Maurer, Angelika Berger-Becvar, György Miklós Keserű, Patrick T. Gunning, Peter Valent & Richard Moriggl. (2018) Emerging therapeutic targets in myeloproliferative neoplasms and peripheral T-cell leukemia and lymphomas. Expert Opinion on Therapeutic Targets 22:1, pages 45-57.
Read now
Pasquale Niscola, Elisabetta Abruzzese, Malgorzata Monika Trawinska, Massimiliano Palombi, Andrea Tendas, Marco Giovannini, Laura Scaramucci, Luca Cupelli, Stefano Fratoni, Nélida Inés Noguera, Gianfranco Catalano & Paolo de Fabritiis. (2017) Decitabine treatment of multiple extramedullary acute myeloid leukemia involvements after essential thrombocytemia transformation. Acta Oncologica 56:10, pages 1331-1333.
Read now
Prithviraj Bose & Srdan Verstovsek. (2016) Myelofibrosis: an update on drug therapy in 2016. Expert Opinion on Pharmacotherapy 17:18, pages 2375-2389.
Read now
Prithviraj Bose & Srdan Verstovsek. (2016) Investigational histone deacetylase inhibitors (HDACi) in myeloproliferative neoplasms. Expert Opinion on Investigational Drugs 25:12, pages 1393-1403.
Read now

Articles from other publishers (2)

Michael Leung, Kaitlin Highsmith & Amber Rexwinkle. (2016) Pharmacologic management of myelofibrosis. Journal of Oncology Pharmacy Practice 23:8, pages 591-601.
Crossref
Rita Assi, Srdan Verstovsek & Naval Daver. (2017) ‘JAK–ing’ up the treatment of primary myelofibrosis. Current Opinion in Hematology 24:2, pages 115-124.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.